The Swiss pharma plans to discontinue small-volume biologics production at its Kleinbasel site by the end of 2027, a move that could eliminate approximately 130 jobs.
https://www.fiercepharma.com/pharma/novartis-telegraphs-130-job-cuts-amid-biologics-rethink-switzerland